ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 284751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 284751; 2) Community: the network communities that were significantly associated with the response to NSC 284751; 3) Molecule: the relationships between components within communities and NSC 284751; 4) MDR: the compounds that were significantly associated with the NSC 284751.

NSC Compound Enrichment Correlation
NSC 751393 2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one 0.0178844438004194 0.30428396
NSC 757113 METHOTREXATE(+/-) 0.0178844438004194 0.42727244
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0178844438004194 0.41345659
NSC 9706 Triethylenemelamine 0.0178844438004194 0.33569084
NSC 112758 Rubomycin 0.0178844438004195 0.13527447
NSC 1390 Allopurinol 0.0178844438004195 0.55945363
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0178844438004195 0.44614825
NSC 264880 Dihydro-5-azacytidine 0.0178844438004195 0.23673713
NSC 269756 Baccharinol B4 0.0178844438004195 -0.055855755
NSC 287459 Cytarabine AY 0.0183522248172065 0.40230213
Total:146  Current:75    [First] [Prev] [Next] [Last]